Literature DB >> 26085874

National rates and risk factors for stent failure after successful insertion in patients with obstructed, infected upper tract stones.

Briony Varda1, Akshay Sood2, Nandita Krishna1, Giorgio Gandaglia3, Jesse D Sammon2, John Zade1, Marianne Schmid1, Kevin C Zorn4, Quoc-Dien Trinh1, Naeem Bhojani4.   

Abstract

INTRODUCTION: We report the incidence of stent failure, defined as the need for salvage percutaneous nephrostomy (PCN) placement following the placement of a ureteral stent, in patients with infection of an obstructed urinary tract secondary to urolithiasis. We also sought to identify risk factors associated with ureteral stent failure.
METHODS: Using the Nationwide Inpatient Sample, we used time trend analysis to examine the incidence of ureteral stent failure for infected urolithiasis, as well as the estimated annual percent change (EAPC) from 1998 to 2010. Logistic regression was performed to estimate the odds of stent failure based on patient and hospital characteristics.
RESULTS: A total of 164 546 stents were placed during the study period. Of these, 97.8% resulted in successful decompression. The rates of successful stent decompression and stent failure increased over time (EAPC 14.05%, p < 0.001; EAPC 11.61%, p < 0.001). Middle-aged males with renal stones and acute kidney failure had higher odds of stent failure (p < 0.05). Salvage percutaneous nephrostomies were performed most frequently in urban teaching institutions (odds ratio [OR] 1.98, p = 0.001; OR 1.83, p < 0.001).
CONCLUSIONS: Ureteral stent decompression for an infected obstructed urinary tract secondary to urolithiasis is almost always effective. For a small proportion of patients, stent failure will occur and will require the placement of a nephrostomy tube. Stent failure is associated with male gender, stone location, and renal failure. Salvage percutaneous nephrostomies for these patients occur most frequently in urban teaching hospitals. Of note, this study was limited by the presumption that coding for a PCN after stent placement indicated stent failure, which could not be verified because of the inherent limitations of the dataset.

Entities:  

Year:  2015        PMID: 26085874      PMCID: PMC4455634          DOI: 10.5489/cuaj.2456

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  18 in total

1.  Quality improvement guidelines for percutaneous nephrostomy.

Authors:  Parvati Ramchandani; John F Cardella; Clement J Grassi; Anne C Roberts; David Sacks; Marc S Schwartzberg; Curtis A Lewis
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

2.  Trends in percutaneous nephrolithotomy use and outcomes in the United States.

Authors:  Khurshid R Ghani; Jesse D Sammon; Naeem Bhojani; Pierre I Karakiewicz; Maxine Sun; Shyam Sukumar; Ray Littleton; James O Peabody; Mani Menon; Quoc-Dien Trinh
Journal:  J Urol       Date:  2013-02-19       Impact factor: 7.450

3.  How do we manage infected, obstructed hydronephrosis?

Authors:  Brian R Matlaga
Journal:  Eur Urol       Date:  2012-10-16       Impact factor: 20.096

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial.

Authors:  H Mokhmalji; P M Braun; F J Martinez Portillo; M Siegsmund; P Alken; K U Köhrmann
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

6.  Optimal prevention and management of proximal ureteral stent migration and remigration.

Authors:  R H Breau; R W Norman
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

7.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

8.  Predicting the success of retrograde stenting for managing ureteral obstruction.

Authors:  O Yossepowitch; D A Lifshitz; Y Dekel; M Gross; D M Keidar; M Neuman; P M Livne; J Baniel
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

9.  Success of ureteral stents for intrinsic ureteral obstruction.

Authors:  David L Wenzler; Simon P Kim; Henry M Rosevear; Gary J Faerber; William W Roberts; J Stuart Wolf
Journal:  J Endourol       Date:  2008-02       Impact factor: 2.942

10.  Emergency percutaneous nephrostomy: results and complications.

Authors:  W J Lee; U Patel; S Patel; G P Pillari
Journal:  J Vasc Interv Radiol       Date:  1994 Jan-Feb       Impact factor: 3.464

View more
  5 in total

Review 1.  Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.

Authors:  Linda Hsu; Hanhan Li; Daniel Pucheril; Moritz Hansen; Raymond Littleton; James Peabody; Jesse Sammon
Journal:  World J Nephrol       Date:  2016-03-06

Review 2.  [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].

Authors:  C Netsch; B Becker; A J Gross
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

3.  Canadian Urological Association guideline: Management of ureteral calculi - Abridged version.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

4.  Canadian Urological Association guideline: Management of ureteral calculi - Full-text.

Authors:  Jason Y Lee; Sero Andonian; Naeem Bhojani; Jennifer Bjazevic; Ben H Chew; Shubha De; Hazem Elmansy; Andrea G Lantz-Powers; Kenneth T Pace; Trevor D Schuler; Rajiv K Singal; Peter Wang; Michael Ordon
Journal:  Can Urol Assoc J       Date:  2021-12       Impact factor: 1.862

5.  Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.

Authors:  Sung Han Kim; Boram Park; Jungnam Joo; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Kang Hyun Lee
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.